Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
AstraZeneca: Reiterate Our Growth Pick
07:33am, Thursday, 16'th Feb 2023
AstraZeneca, profit beats expectations. But revenues are down due to lower COVID-19 sales. In 2023, almost zero vaccine intake. However, we are estimating a double-digit revenue growth thanks to Tagri
Ironwood (IRWD) Gets FDA Priority Tag for Linzess sNDA
12:20pm, Tuesday, 14'th Feb 2023 Zacks Investment Research
With the FDA granting priority review to Ironwood Pharmaceuticals' (IRWD) sNDA seeking label expansion of Linzess for functional constipation in kids, a decision is expected in the second quarter of 2
AstraZeneca pipeline worth the current premium, says broker
04:31am, Tuesday, 14'th Feb 2023
Shore Capital has reiterated its 'buy' recommendation for AstraZeneca PLC (LSE:AZN) following the release of the company's fourth-quarter results, following which it also reiterated its above consens
There's a Lot to Love About Mineralys' Valentine's Day IPO
09:23am, Monday, 13'th Feb 2023
It has been less than a year since Mineralys Therapeutics (NASDAQ: MLYS) listed its IPO, but the activity has been quite hot, particularly since the top of the year. With 2.71 million in trading volum
Pharma Stock Roundup: AZN, ABBV Mixed Q4 Results, BAYRY's New CEO
02:05pm, Friday, 10'th Feb 2023 Zacks Investment Research
AstraZeneca (AZN) and AbbVie (ABBV) report fourth-quarter results. Roche (RHHBY) and J&J (JNJ) announce positive data from studies on pipeline candidates for rare diseases.
AstraZeneca Plc (AZN) Q4 2022 Earnings Call Transcript
01:30am, Friday, 10'th Feb 2023 The Motley Fool
AZN earnings call for the period ending December 31, 2022.
Omicron strains remain dominant globally, and the WHO is monitoring four closely
07:50pm, Thursday, 09'th Feb 2023 MarketWatch
The omicron strain of the coronavirus that causes COVID and its descendent lineages are still dominant globally, and XBB.1.5 is under monitoring.
Astrazeneca (AZN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
05:08pm, Thursday, 09'th Feb 2023 Zacks Investment Research
Although the revenue and EPS for Astrazeneca (AZN) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall S
AstraZeneca PLC (AZN) Q4 2022 Earnings Call Transcript
03:03pm, Thursday, 09'th Feb 2023
AstraZeneca PLC (NASDAQ:AZN ) Q4 2022 Earnings Conference Call February 9, 2023 6:45 AM ET Company Participants Andy Barnett - Head of Investor Relations Pascal Soriot - Executive Director & Chief Exe
2 Top Biotech Stocks to Buy Right Now
02:37pm, Thursday, 09'th Feb 2023 The Motley Fool
These two companies each pay market-beating dividends to shareholders.
AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab
01:39pm, Thursday, 09'th Feb 2023 Zacks Investment Research
AstraZeneca (AZN) beats fourth-quarter estimates for earnings while missing the same for sales.
Astrazeneca (AZN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
01:34pm, Thursday, 09'th Feb 2023
Although the revenue and EPS for Astrazeneca (AZN) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall S
US Stocks On Recovery Course As Earnings Lend Support: Fed's Hawkish Stance May Unwind Rally In High-Value Names, Says Analyst
11:45am, Thursday, 09'th Feb 2023 Benzinga
The see-sawing mood in the market continues as Fed’s data dependency creates volatility. The index futures point to a solidly higher opening on Thursday, signaling a reversal in the sentiment seen
How To Allocate $5,000 Among 5 Dividend Income And Dividend Growth Stocks And ETFs
09:48am, Thursday, 09'th Feb 2023
In this article, I will show you a portfolio that consists of 5 picks that provide you with Dividend Income and Dividend Growth. When allocating $5,000 between 5 stocks, I would not recommend allocati
AstraZeneca Stock Jumps As Upbeat Guidance Offsets Mixed Quarterly Report
09:22am, Thursday, 09'th Feb 2023
AstraZeneca's earnings topped forecasts Thursday, but sales came in light. AZN stock rose on its upbeat 2023 guidance.
